Autor: |
Elimian, K. O., Ochu, C. L., Ilori, E., Oladejo, J., Igumbor, E., Steinhardt, L., Wagai, J., Arinze, C., Ukponu, W., Obiekea, C., Aderinola, O., Crawford, E., Olayinka, A., Dan-Nwafor, C., Okwor, T., Disu, Y., YinkaOgunleye, A., Kanu, N. E., Olawepo, O. A., Aruna, O. |
Zdroj: |
Epidemiology & Infection; Jan2020, Vol. 148, p1-16, 16p, 5 Charts, 2 Graphs, 1 Map |
Abstrakt: |
The objective of this study was to describe the epidemiology of COVID-19 in Nigeria with a view of generating evidence to enhance planning and response strategies. A national surveillance dataset between 27 February and 6 June 2020 was retrospectively analysed, with confirmatory testing for COVID-19 done by real-time polymerase chain reaction (RT-PCR). The primary outcomes were cumulative incidence (CI) and case fatality (CF). A total of 40 926 persons (67% of total 60 839) had complete records of RT-PCR test across 35 states and the Federal Capital Territory, 12 289 (30.0%) of whom were confirmed COVID-19 cases. Of those confirmed cases, 3467 (28.2%) had complete records of clinical outcome (alive or dead), 342 (9.9%) of which died. The overall CI and CF were 5.6 per 100 000 population and 2.8%, respectively. The highest proportion of COVID-19 cases and deaths were recorded in persons aged 31–40 years (25.5%) and 61–70 years (26.6%), respectively; and males accounted for a higher proportion of confirmed cases (65.8%) and deaths (79.0%). Sixty-six per cent of confirmed COVID-19 cases were asymptomatic at diagnosis. In conclusion, this paper has provided an insight into the early epidemiology of COVID-19 in Nigeria, which could be useful for contextualising public health planning. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|